Navigation Links
TripleMaster PCR System

on. Start with 35 cycles, if necessary, increase up to 45 cycles.
2 Determine the optimal annealing temperature empirically.
3Optimize elongation temperature. Increasing temperature >72C is not recommended for targets >5 kb due to temperature-driven damage of template DNA.
4 The elongation time depends on fragment length and template complexity. Use the upper values for each fragment size range given in Table 7 to amplify GC-rich targets. Further increase the elongation time if the product yield is still low or a background smear occurs.

10 Troubleshooting

Follow the manual as written!

10.1 No product


- Check the quality of primers and template. - Check the annealing and denaturation temperatures (especially for GC-rich targets). - Increase number of cycles (by steps of 5). - Increase template DNA by 50 ng increments. - Increase enzyme concentration (up to 2.5 U per 50 l). - Check the fit of the PCR tubes to the appropriate cycler. Bad contact affects temperature transfer. Use only consumables recommended by the cycler manufacturer. - Prevent air bubbles from becoming trapped after mixing the reaction Mastermixes. Air bubbles prevent homogenous temperature distribution throughout the reaction volume. - Check the fit of PCR tube caps or sealin
'"/>

Source:


Page: All 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Related biology technology :

1. TripleMaster PCR System
2. The TripleMaster PCR System for three different amplifications
3. TripleMaster PCR System: Direct Comparison with Competitors
4. TripleMaster and Perfect gDNA Blood Mini Kit Team Up to Amplify Long gDNA Templates
5. TripleMaster PCR SystemThe Ideal Choice for Long-Range PCR
6. Using the TripleMaster PCR System for Robust Amplification of GC-Rich DNA Templates
7. New Mammalian Two-Hybrid System Detects Protein-Protein Interactions
8. Assess the In Vivo Activation of Signal Transduction Pathways with PathDetect Reporting Systems
9. Generate Adenovirus Vectors in E. coli by Homologous Recombination with the AdEasy Adenoviral Vector System
10. New Yeast Cloning System for Producing Proteins with Native Amino Acid Sequences
11. Enhanced PCR Cloning System
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: TripleMaster PCR System

(Date:12/16/2009)... Decision Resources, one of the world,s ... healthcare issues, finds that, according to responses from ... briakinumab (both interleukin inhibitors) will capture 22 percent ... drug market for moderate to severe psoriasis. Among ... capturing nearly three times as much patient share ...
(Date:12/16/2009)... conducted pursuant to Special Protocol Assessment with ... CITY, Dec. 16 /PRNewswire-FirstCall/ - AEterna Zentaris ... (the "Company"), a global biopharmaceutical company focused ... the initiation, by its partner Keryx Biopharmaceuticals ... 3 registration clinical trial for perifosine (KRX-0401), ...
(Date:12/16/2009)... A has been found to be effectinve in improving yelds of ... ... Nu-Tek BioSciences, LLC. ( www.nu-tekproducts.com ) is meeting the demand for ... by Nutricepts, Inc. (Burnsville, Mn), is a high quality Soy Peptone. ... HSP-A has been found to be especially effective in improving yields ...
(Date:12/15/2009)... Joint BioEnergy Institute (JBEI), one of three Department of ... trusted time-stamping service to protect its valuable intellectual property. ... ... VA (PRWEB) December 15, 2009 -- Surety, LLC ... solutions , today announced that the Joint BioEnergy Institute ...
Breaking Biology Technology:In 2012, Stelara and Briakinumab Will Capture 22 Percent of the Biologics Share in the Moderate to Severe Psoriasis Drug Market 2In 2012, Stelara and Briakinumab Will Capture 22 Percent of the Biologics Share in the Moderate to Severe Psoriasis Drug Market 3AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 2AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 3AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 4AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 5Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 2Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 3Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 4Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 5
... N.Y. A new technique for growing single-crystal ... enable the development of smaller, more powerful heat ... , Researchers at Rensselaer Polytechnic Institute have discovered ... up of two single crystals using a biomolecular ...
... with,CorVel Corporation,s (Nasdaq: CRVL ) quarterly earnings release, CorVel will,be conducting ... August 5th at 11:30 am Eastern Time., Event: ... Dan Starck, President and CEO ... 11:30 am Eastern Time, Tuesday, August 5th, ...
... 17 Researchers at Fred Hutchinson Cancer,Research Center ... the,National Human Genome Research Institute to better understand ... Hutchinson Center is one of,four U.S. research institutes ... effort., The Hutchinson Center project, led by ...
Other Biology Technology:'Nanosculpture' could enable new types of heat pumps and energy converters 2CorVel Corporation Announces Earnings Release Webcast 2Hutchinson Center Receives $7.6 Million Federal Grant to Study How Genetic Variations Influence Risk of Common Diseases 2Hutchinson Center Receives $7.6 Million Federal Grant to Study How Genetic Variations Influence Risk of Common Diseases 3
(Date:12/16/2009)... 9 BIO-key International, Inc. (OTC ... biometric identification solutions, today announced that SC ... security publications, named BIO-key International the 2009 ... Control sub-category Biometrics. ,, (Logo: ... technology editor, SC Magazine, "Biometric providers have ...
(Date:12/15/2009)... 15 The 2009 Frost & ... is presented to Sagem Securite (Safran Group) ... The award recognises the company,s expertise in ... in offering novel, value-added products to end ... ) ,, "Sagem Securite has been involved ...
(Date:12/15/2009)... the British Society for Research on Ageing (BSRA) to ... for an initial period of three years. ... Biogerontology editorial board and will acquire articles for ... society and provide society members with free electronic access ... Biogerontology offers a platform for research which ...
Breaking Biology News(10 mins):BIO-key(R) Selected as 2009 Industry Innovator in Biometrics by SC Magazine 2BIO-key(R) Selected as 2009 Industry Innovator in Biometrics by SC Magazine 3Frost & Sullivan Recognises Sagem Securite for its Innovative Automated Border Control Systems 2Frost & Sullivan Recognises Sagem Securite for its Innovative Automated Border Control Systems 3Frost & Sullivan Recognises Sagem Securite for its Innovative Automated Border Control Systems 4Auroras Milwaukee Hospitals Recognized in US News and World Report 51970 1Auroras Milwaukee Hospitals Recognized in US News and World Report 51970 2VIVIMIND 28TM 29 granted certificate of free sale as food supplement in Italy Premarket notification filed in the U S 51966 1VIVIMIND 28TM 29 granted certificate of free sale as food supplement in Italy Premarket notification filed in the U S 51966 2VIVIMIND 28TM 29 granted certificate of free sale as food supplement in Italy Premarket notification filed in the U S 51966 3Omnicell to Release Second Quarter 2009 Earnings Results on July 23 51961 1Omnicell to Release Second Quarter 2009 Earnings Results on July 23 51961 2
... in culture to mimic the properties of the heart ... the mechanisms that spawn irregular heart rhythms. Studies of ... such as those delivered by defibrillators usually stopped aberrant ... and multiply. , The Duke University and Johns Hopkins ...
... the Food and Drug Administration's clearance of a new ... technology developed at the university. This action signals a ... prosthetic replacements toward regenerative medicine, in which materials help ... , The device consists of a surgical mesh ...
... single gene apparently thwarts a disease-causing invader that creates ... But the same gene provides access to a different ... biologist and his collaborators in Austria and North Carolina ... also triggers a defense against disease. The gene and ...
Other Biology News:Engineered heart tissue offers insights into irregular heartbeats, defibrillator failure 2Engineered heart tissue offers insights into irregular heartbeats, defibrillator failure 3FDA approves first medical device using rutgers biomaterial 2Gene thwarts some pathogens, gives access to others, could save crops 2Gene thwarts some pathogens, gives access to others, could save crops 3
Phospho-TAK1 (Thr184/187) (90C7) Rabbit mAb Shipping Temperature: Cold Storage Temperature: -20C...
... polyclonal to MSY2/YBOX2 ( Abpromise ... Antigen: Synthetic peptide derived ... C-terminus of Human MSY2/YBOX2. (Note: ... (Peptide available as ...
SAPK/JNK Antibody...
...
Biology Products: